A detailed history of Ra Capital Management, L.P. transactions in Chimerix Inc stock. As of the latest transaction made, Ra Capital Management, L.P. holds 8,800,000 shares of CMRX stock, worth $26.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,800,000
Previous 8,800,000 -0.0%
Holding current value
$26.3 Million
Previous $7.74 Million 5.68%
% of portfolio
0.11%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.05 $7.66 Million - $9.24 Million
8,800,000 New
8,800,000 $7.74 Million
Q4 2023

Feb 14, 2024

BUY
$0.9 - $1.06 $7.92 Million - $9.33 Million
8,800,000 New
8,800,000 $8.45 Million
Q3 2023

Nov 14, 2023

BUY
$0.94 - $1.23 $6.11 Million - $8 Million
6,501,624 New
6,501,624 $6.24 Million
Q4 2019

Feb 14, 2020

SELL
$1.3 - $2.72 $2.32 Million - $4.85 Million
-1,782,202 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.93 - $4.21 $3.44 Million - $7.5 Million
1,782,202 New
1,782,202 $4.19 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $262M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.